Find Leading Growth Stocks Using The IBD Composite Rating | Learn How To Invest: IBD

TL;DR

IBD's composite rating, on a scale of 1 to 99, helps investors identify stocks that have outperformed a majority of other stocks based on key fundamental and technical metrics. When combined with the relative strength rating, it can help pinpoint leading growth stocks for further analysis.

Transcript

to help investors map out their portfolio strategy and cut down time on stock screening ibd has developed proprietary ratings that help reveal leading stocks before they make their big moves one of the main instruments in that ibd toolbox is the composite rating the composite rating which ranges from one the worst to 99 the best provides an overall... Read More

Key Insights

• 🤩 IBD's composite rating helps investors identify stocks that have outperformed a majority of other stocks based on key fundamental and technical metrics.
• 👨‍🔬 While the composite rating is a valuable tool, it should be supplemented with thorough research and consideration of current market trends.
• 🥺 The relative strength rating can be used alongside the composite rating to identify leading growth stocks.
• ✋ Screening for stocks with both high composite ratings and relative strength ratings over 90 can efficiently narrow down the universe of potential investments.
• 😚 The composite rating is just a starting point and should be followed by a closer investigation of a stock's fundamentals, chart patterns, and average daily trading volume.
• 🏍️ Companies that are innovative and have the potential to be growth leaders in a given market cycle should be prioritized.
• 💁 IBD's stock screener tool and other platforms provide a wealth of information to support investors in their stock selection process.

Questions & Answers

Q: What is IBD's composite rating and how does it help investors?

IBD's composite rating is a score that combines five different ratings to give an overall assessment of a stock's performance. It helps investors identify stocks that have outperformed a majority of other stocks based on key fundamental and technical metrics.

Q: Is the composite rating the only factor to consider when selecting stocks?

No, the composite rating is just a starting point. It should be supplemented with research, consideration of current market trends, and identifying companies with innovative potential. It is important to do a thorough analysis before making any investment decisions.

Q: How can investors use the relative strength rating alongside the composite rating?

Investors can screen for stocks that have both high composite ratings and relative strength ratings above 90. The relative strength rating compares a stock's price performance to all other stocks in the market over the past 52 weeks, helping to identify leading growth stocks.

Q: Can the composite rating be found on IBD's platforms?

Yes, the composite rating is listed on many charts of IBD's stock lists, including the IBD 50 and big cap 20. IBD's stock screener tool also curates its proprietary stock lists, making it easy to find stocks with high composite ratings.

Summary & Key Takeaways

• IBD's composite rating is an overall score that assesses a stock's performance based on five different ratings: EPS rating, relative strength rating, SMR rating, accumulation distribution rating, and recent price action.

• The composite rating is a relative measure, comparing a stock's performance to all other stocks in the market.

• While the composite rating is a useful starting point, it should be supplemented with research, consideration of market trends, and identifying companies with innovative potential.